E Fund Management (HK)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$423K Buy
844
+793
+1,555% +$381K 0.14% 100
2026
Q1
$25.1K Sell
51
-366
-88% -$199K 0.01% 198
2025
Q4
$243K Buy
417
+414
+13,800% +$234K 0.08% 105
2025
Q3
$1.46K Buy
+3
New +$1.4K ﹤0.01% 181
2024
Q4
Sell
-291
Closed -$180K 188
2024
Q3
$180K Buy
291
+100
+52% +$59.2K 0.11% 34
2024
Q2
$106K Hold
191
0.07% 38
2024
Q1
$111K Buy
191
+30
+19% +$16.8K 0.07% 43
2023
Q4
$85K Buy
161
+59
+58% +$28.6K 0.05% 43
2023
Q3
$52K Buy
+102
New +$54.4K 0.03% 34

Other funds holding TMO

E Fund Management (HK)'s TMO Position: Q2 2026 in Review

E Fund Management (HK) increased its Thermo Fisher Scientific (TMO) stake by 1,555% in Q2 2026, buying an estimated $381K and bringing the position to 844 shares worth $423K. The position accounts for 0.14% of the portfolio, ranked #100.

E Fund Management (HK) first reported a position in TMO in Q3 2023 and has held it in 9 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • E Fund Management (HK) held 844 shares of Thermo Fisher Scientific worth $423K as of Q2 2026.
  • E Fund Management (HK) bought 793 Thermo Fisher Scientific shares in Q2 2026, an estimated $381K.
  • Thermo Fisher Scientific made up 0.14% of E Fund Management (HK)'s portfolio in Q2 2026, its #100 holding.
  • E Fund Management (HK) first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 9 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.